MoonLake Immunotherapeutics - Class A

MLTX NASDAQ Santé & Biotech Suisse KY61559X1045
18.27 $
0.92 %

MoonLake Immunotherapeutics se consacre à développer des thérapies innovantes basées sur les nanocorps pour le traitement des maladies inflammatoires.

Price history of MoonLake Immunotherapeutics - Class A
Price history of MoonLake Immunotherapeutics - Class A

Performance & Momentum

6 Months 21.84 %
1 Year 64.21 %
3 Years 33.83 %
5 Years 81.79 %

Similar stocks to MoonLake Immunotherapeutics - Class A

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone